nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—Methotrexate—germ cell cancer	0.684	1	CbGbCtD
Brimonidine—Clonidine—SLC22A3—germ cell cancer	0.0166	1	CrCbGaD
Brimonidine—Pain of skin—Bleomycin—germ cell cancer	0.0145	0.0576	CcSEcCtD
Brimonidine—Rash papular—Ifosfamide—germ cell cancer	0.00786	0.0311	CcSEcCtD
Brimonidine—Hypoxia—Ifosfamide—germ cell cancer	0.00461	0.0183	CcSEcCtD
Brimonidine—Blindness—Cisplatin—germ cell cancer	0.00456	0.0181	CcSEcCtD
Brimonidine—Photophobia—Vinblastine—germ cell cancer	0.00381	0.0151	CcSEcCtD
Brimonidine—Eye irritation—Ifosfamide—germ cell cancer	0.00343	0.0136	CcSEcCtD
Brimonidine—Cyanosis—Etoposide—germ cell cancer	0.00327	0.0129	CcSEcCtD
Brimonidine—Respiratory failure—Ifosfamide—germ cell cancer	0.00298	0.0118	CcSEcCtD
Brimonidine—Apnoea—Etoposide—germ cell cancer	0.00273	0.0108	CcSEcCtD
Brimonidine—Coma—Ifosfamide—germ cell cancer	0.00268	0.0106	CcSEcCtD
Brimonidine—AOX1—trigeminal ganglion—germ cell cancer	0.00259	0.0547	CbGeAlD
Brimonidine—Arthritis—Bleomycin—germ cell cancer	0.00256	0.0101	CcSEcCtD
Brimonidine—Osteoporosis—Methotrexate—germ cell cancer	0.00247	0.00979	CcSEcCtD
Brimonidine—Swelling—Ifosfamide—germ cell cancer	0.00241	0.00954	CcSEcCtD
Brimonidine—Lethargy—Dactinomycin—germ cell cancer	0.00237	0.00938	CcSEcCtD
Brimonidine—Depression—Vinblastine—germ cell cancer	0.00226	0.00896	CcSEcCtD
Brimonidine—AOX1—eye—germ cell cancer	0.00223	0.0471	CbGeAlD
Brimonidine—Hypoxia—Methotrexate—germ cell cancer	0.00218	0.00864	CcSEcCtD
Brimonidine—Osteoarthritis—Ifosfamide—germ cell cancer	0.00213	0.00842	CcSEcCtD
Brimonidine—Pharyngitis—Vinblastine—germ cell cancer	0.00202	0.00801	CcSEcCtD
Brimonidine—Nasal congestion—Cisplatin—germ cell cancer	0.00201	0.00797	CcSEcCtD
Brimonidine—Burning sensation—Methotrexate—germ cell cancer	0.00199	0.0079	CcSEcCtD
Brimonidine—Cyanosis—Methotrexate—germ cell cancer	0.00196	0.00775	CcSEcCtD
Brimonidine—AOX1—decidua—germ cell cancer	0.00193	0.0407	CbGeAlD
Brimonidine—Swelling—Etoposide—germ cell cancer	0.0019	0.00754	CcSEcCtD
Brimonidine—Face oedema—Cisplatin—germ cell cancer	0.00177	0.00701	CcSEcCtD
Brimonidine—AOX1—gonad—germ cell cancer	0.0017	0.0358	CbGeAlD
Brimonidine—AOX1—uterus—germ cell cancer	0.00169	0.0356	CbGeAlD
Brimonidine—AOX1—pituitary gland—germ cell cancer	0.00166	0.035	CbGeAlD
Brimonidine—Nasopharyngitis—Cisplatin—germ cell cancer	0.00164	0.00649	CcSEcCtD
Brimonidine—ADRA2C—trigeminal ganglion—germ cell cancer	0.00164	0.0346	CbGeAlD
Brimonidine—Apnoea—Methotrexate—germ cell cancer	0.00163	0.00647	CcSEcCtD
Brimonidine—Flushing—Bleomycin—germ cell cancer	0.0016	0.00633	CcSEcCtD
Brimonidine—Pharyngitis—Dactinomycin—germ cell cancer	0.00159	0.00631	CcSEcCtD
Brimonidine—Conjunctivitis—Ifosfamide—germ cell cancer	0.00159	0.00631	CcSEcCtD
Brimonidine—Hypertension—Vinblastine—germ cell cancer	0.00153	0.00607	CcSEcCtD
Brimonidine—Erythema—Bleomycin—germ cell cancer	0.0015	0.00593	CcSEcCtD
Brimonidine—Bradycardia—Ifosfamide—germ cell cancer	0.0015	0.00593	CcSEcCtD
Brimonidine—Discomfort—Vinblastine—germ cell cancer	0.00149	0.00591	CcSEcCtD
Brimonidine—Flushing—Dactinomycin—germ cell cancer	0.00149	0.0059	CcSEcCtD
Brimonidine—AOX1—adrenal gland—germ cell cancer	0.00148	0.0312	CbGeAlD
Brimonidine—Visual impairment—Ifosfamide—germ cell cancer	0.00142	0.00561	CcSEcCtD
Brimonidine—Respiratory failure—Methotrexate—germ cell cancer	0.00141	0.00559	CcSEcCtD
Brimonidine—Erythema—Dactinomycin—germ cell cancer	0.0014	0.00553	CcSEcCtD
Brimonidine—AOX1—female gonad—germ cell cancer	0.00138	0.0291	CbGeAlD
Brimonidine—Eye disorder—Ifosfamide—germ cell cancer	0.00137	0.00544	CcSEcCtD
Brimonidine—Conjunctivitis—Cisplatin—germ cell cancer	0.00137	0.00544	CcSEcCtD
Brimonidine—Cardiac disorder—Ifosfamide—germ cell cancer	0.00137	0.00541	CcSEcCtD
Brimonidine—Flushing—Ifosfamide—germ cell cancer	0.00137	0.00541	CcSEcCtD
Brimonidine—Angiopathy—Ifosfamide—germ cell cancer	0.00133	0.00529	CcSEcCtD
Brimonidine—Immune system disorder—Ifosfamide—germ cell cancer	0.00133	0.00526	CcSEcCtD
Brimonidine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00133	0.00525	CcSEcCtD
Brimonidine—Arrhythmia—Ifosfamide—germ cell cancer	0.00131	0.0052	CcSEcCtD
Brimonidine—Cough—Bleomycin—germ cell cancer	0.00131	0.00518	CcSEcCtD
Brimonidine—ADRA2A—trigeminal ganglion—germ cell cancer	0.00131	0.0276	CbGeAlD
Brimonidine—Paraesthesia—Vinblastine—germ cell cancer	0.0013	0.00515	CcSEcCtD
Brimonidine—Bradycardia—Cisplatin—germ cell cancer	0.00129	0.00511	CcSEcCtD
Brimonidine—Mental disorder—Ifosfamide—germ cell cancer	0.00129	0.0051	CcSEcCtD
Brimonidine—ADRA2C—telencephalon—germ cell cancer	0.00129	0.0271	CbGeAlD
Brimonidine—AOX1—endocrine gland—germ cell cancer	0.00128	0.0271	CbGeAlD
Brimonidine—Erythema—Ifosfamide—germ cell cancer	0.00128	0.00507	CcSEcCtD
Brimonidine—Chest pain—Bleomycin—germ cell cancer	0.00128	0.00505	CcSEcCtD
Brimonidine—Myalgia—Bleomycin—germ cell cancer	0.00128	0.00505	CcSEcCtD
Brimonidine—Coma—Methotrexate—germ cell cancer	0.00127	0.00501	CcSEcCtD
Brimonidine—Discomfort—Bleomycin—germ cell cancer	0.00126	0.00499	CcSEcCtD
Brimonidine—Pain—Vinblastine—germ cell cancer	0.00124	0.0049	CcSEcCtD
Brimonidine—AOX1—testis—germ cell cancer	0.00122	0.0258	CbGeAlD
Brimonidine—Oedema—Bleomycin—germ cell cancer	0.00122	0.00484	CcSEcCtD
Brimonidine—Visual impairment—Cisplatin—germ cell cancer	0.00122	0.00484	CcSEcCtD
Brimonidine—ADRA2C—decidua—germ cell cancer	0.00122	0.0257	CbGeAlD
Brimonidine—Infection—Bleomycin—germ cell cancer	0.00121	0.00481	CcSEcCtD
Brimonidine—Vision blurred—Ifosfamide—germ cell cancer	0.00121	0.00478	CcSEcCtD
Brimonidine—Myalgia—Dactinomycin—germ cell cancer	0.00119	0.00471	CcSEcCtD
Brimonidine—Eye disorder—Cisplatin—germ cell cancer	0.00119	0.00469	CcSEcCtD
Brimonidine—Flushing—Cisplatin—germ cell cancer	0.00118	0.00466	CcSEcCtD
Brimonidine—Cardiac disorder—Cisplatin—germ cell cancer	0.00118	0.00466	CcSEcCtD
Brimonidine—Discomfort—Dactinomycin—germ cell cancer	0.00118	0.00465	CcSEcCtD
Brimonidine—Diabetes mellitus—Methotrexate—germ cell cancer	0.00116	0.00458	CcSEcCtD
Brimonidine—Immune system disorder—Cisplatin—germ cell cancer	0.00115	0.00454	CcSEcCtD
Brimonidine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00114	0.00453	CcSEcCtD
Brimonidine—Hypotension—Bleomycin—germ cell cancer	0.00114	0.00452	CcSEcCtD
Brimonidine—Oedema—Dactinomycin—germ cell cancer	0.00114	0.00452	CcSEcCtD
Brimonidine—Infection—Dactinomycin—germ cell cancer	0.00113	0.00449	CcSEcCtD
Brimonidine—Arrhythmia—Cisplatin—germ cell cancer	0.00113	0.00449	CcSEcCtD
Brimonidine—Palpitations—Ifosfamide—germ cell cancer	0.00113	0.00448	CcSEcCtD
Brimonidine—AOX1—cerebellum—germ cell cancer	0.00113	0.0239	CbGeAlD
Brimonidine—Cough—Ifosfamide—germ cell cancer	0.00112	0.00443	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00111	0.00441	CcSEcCtD
Brimonidine—Hypertension—Ifosfamide—germ cell cancer	0.00111	0.00438	CcSEcCtD
Brimonidine—Erythema—Cisplatin—germ cell cancer	0.0011	0.00437	CcSEcCtD
Brimonidine—Paraesthesia—Bleomycin—germ cell cancer	0.0011	0.00435	CcSEcCtD
Brimonidine—Dyspnoea—Bleomycin—germ cell cancer	0.00109	0.00432	CcSEcCtD
Brimonidine—Myalgia—Ifosfamide—germ cell cancer	0.00109	0.00432	CcSEcCtD
Brimonidine—Chest pain—Ifosfamide—germ cell cancer	0.00109	0.00432	CcSEcCtD
Brimonidine—Arthralgia—Ifosfamide—germ cell cancer	0.00109	0.00432	CcSEcCtD
Brimonidine—Eye disorder—Etoposide—germ cell cancer	0.00109	0.0043	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00108	0.00429	CcSEcCtD
Brimonidine—Flushing—Etoposide—germ cell cancer	0.00108	0.00427	CcSEcCtD
Brimonidine—Cardiac disorder—Etoposide—germ cell cancer	0.00108	0.00427	CcSEcCtD
Brimonidine—Discomfort—Ifosfamide—germ cell cancer	0.00108	0.00427	CcSEcCtD
Brimonidine—Hypersensitivity—Vinblastine—germ cell cancer	0.00107	0.00422	CcSEcCtD
Brimonidine—ADRA2C—uterus—germ cell cancer	0.00107	0.0225	CbGeAlD
Brimonidine—Visual disturbance—Methotrexate—germ cell cancer	0.00106	0.0042	CcSEcCtD
Brimonidine—Angiopathy—Etoposide—germ cell cancer	0.00105	0.00417	CcSEcCtD
Brimonidine—Immune system disorder—Etoposide—germ cell cancer	0.00105	0.00416	CcSEcCtD
Brimonidine—Mediastinal disorder—Etoposide—germ cell cancer	0.00105	0.00415	CcSEcCtD
Brimonidine—ADRA2C—pituitary gland—germ cell cancer	0.00105	0.0221	CbGeAlD
Brimonidine—Pain—Bleomycin—germ cell cancer	0.00105	0.00414	CcSEcCtD
Brimonidine—Oedema—Ifosfamide—germ cell cancer	0.00105	0.00414	CcSEcCtD
Brimonidine—Vision blurred—Cisplatin—germ cell cancer	0.00104	0.00412	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00104	0.00411	CcSEcCtD
Brimonidine—Asthenia—Vinblastine—germ cell cancer	0.00104	0.00411	CcSEcCtD
Brimonidine—Infection—Ifosfamide—germ cell cancer	0.00104	0.00411	CcSEcCtD
Brimonidine—Lethargy—Methotrexate—germ cell cancer	0.00103	0.00407	CcSEcCtD
Brimonidine—ADRA2A—telencephalon—germ cell cancer	0.00103	0.0217	CbGeAlD
Brimonidine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00102	0.00406	CcSEcCtD
Brimonidine—Skin disorder—Ifosfamide—germ cell cancer	0.00102	0.00402	CcSEcCtD
Brimonidine—ADRA2C—medulla oblongata—germ cell cancer	0.00101	0.0213	CbGeAlD
Brimonidine—Osteoarthritis—Methotrexate—germ cell cancer	0.00101	0.00398	CcSEcCtD
Brimonidine—Dysgeusia—Etoposide—germ cell cancer	0.00099	0.00392	CcSEcCtD
Brimonidine—Fatigue—Dactinomycin—germ cell cancer	0.000983	0.00389	CcSEcCtD
Brimonidine—Hypotension—Ifosfamide—germ cell cancer	0.000977	0.00387	CcSEcCtD
Brimonidine—Pain—Dactinomycin—germ cell cancer	0.000975	0.00386	CcSEcCtD
Brimonidine—ADRA2A—decidua—germ cell cancer	0.000972	0.0205	CbGeAlD
Brimonidine—Dizziness—Vinblastine—germ cell cancer	0.000957	0.00379	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000952	0.00377	CcSEcCtD
Brimonidine—Myalgia—Cisplatin—germ cell cancer	0.00094	0.00372	CcSEcCtD
Brimonidine—Paraesthesia—Ifosfamide—germ cell cancer	0.000938	0.00372	CcSEcCtD
Brimonidine—Anxiety—Cisplatin—germ cell cancer	0.000937	0.00371	CcSEcCtD
Brimonidine—ADRA2C—adrenal gland—germ cell cancer	0.000935	0.0197	CbGeAlD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000933	0.0037	CcSEcCtD
Brimonidine—Dyspnoea—Ifosfamide—germ cell cancer	0.000932	0.00369	CcSEcCtD
Brimonidine—Somnolence—Ifosfamide—germ cell cancer	0.000929	0.00368	CcSEcCtD
Brimonidine—Discomfort—Cisplatin—germ cell cancer	0.000929	0.00368	CcSEcCtD
Brimonidine—ADRA2C—midbrain—germ cell cancer	0.000923	0.0195	CbGeAlD
Brimonidine—AOX1—brain—germ cell cancer	0.000918	0.0194	CbGeAlD
Brimonidine—Headache—Vinblastine—germ cell cancer	0.000907	0.00359	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000902	0.00357	CcSEcCtD
Brimonidine—Fatigue—Ifosfamide—germ cell cancer	0.000901	0.00357	CcSEcCtD
Brimonidine—Oedema—Cisplatin—germ cell cancer	0.000901	0.00357	CcSEcCtD
Brimonidine—Hypersensitivity—Bleomycin—germ cell cancer	0.000901	0.00357	CcSEcCtD
Brimonidine—ADRA2C—spinal cord—germ cell cancer	0.000901	0.019	CbGeAlD
Brimonidine—Infection—Cisplatin—germ cell cancer	0.000895	0.00354	CcSEcCtD
Brimonidine—Pain—Ifosfamide—germ cell cancer	0.000894	0.00354	CcSEcCtD
Brimonidine—Loss of consciousness—Etoposide—germ cell cancer	0.000889	0.00352	CcSEcCtD
Brimonidine—AOX1—lymph node—germ cell cancer	0.000887	0.0187	CbGeAlD
Brimonidine—Nervous system disorder—Cisplatin—germ cell cancer	0.000884	0.0035	CcSEcCtD
Brimonidine—Cough—Etoposide—germ cell cancer	0.000883	0.00349	CcSEcCtD
Brimonidine—Tachycardia—Cisplatin—germ cell cancer	0.000879	0.00348	CcSEcCtD
Brimonidine—Asthenia—Bleomycin—germ cell cancer	0.000877	0.00347	CcSEcCtD
Brimonidine—Skin disorder—Cisplatin—germ cell cancer	0.000875	0.00347	CcSEcCtD
Brimonidine—Hypertension—Etoposide—germ cell cancer	0.000873	0.00346	CcSEcCtD
Brimonidine—ADRA2C—female gonad—germ cell cancer	0.000872	0.0184	CbGeAlD
Brimonidine—Pruritus—Bleomycin—germ cell cancer	0.000865	0.00343	CcSEcCtD
Brimonidine—Chest pain—Etoposide—germ cell cancer	0.000861	0.00341	CcSEcCtD
Brimonidine—Nausea—Vinblastine—germ cell cancer	0.00086	0.00341	CcSEcCtD
Brimonidine—ADRA2A—gonad—germ cell cancer	0.000856	0.0181	CbGeAlD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000855	0.00339	CcSEcCtD
Brimonidine—Discomfort—Etoposide—germ cell cancer	0.000851	0.00337	CcSEcCtD
Brimonidine—ADRA2A—uterus—germ cell cancer	0.00085	0.018	CbGeAlD
Brimonidine—Hypotension—Cisplatin—germ cell cancer	0.000842	0.00333	CcSEcCtD
Brimonidine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00084	0.00333	CcSEcCtD
Brimonidine—ADRA2A—pituitary gland—germ cell cancer	0.000835	0.0176	CbGeAlD
Brimonidine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000821	0.00325	CcSEcCtD
Brimonidine—Infection—Etoposide—germ cell cancer	0.00082	0.00325	CcSEcCtD
Brimonidine—Asthenia—Dactinomycin—germ cell cancer	0.000818	0.00324	CcSEcCtD
Brimonidine—Paraesthesia—Cisplatin—germ cell cancer	0.000809	0.0032	CcSEcCtD
Brimonidine—ADRA2A—medulla oblongata—germ cell cancer	0.000806	0.017	CbGeAlD
Brimonidine—Tachycardia—Etoposide—germ cell cancer	0.000806	0.00319	CcSEcCtD
Brimonidine—Dyspnoea—Cisplatin—germ cell cancer	0.000803	0.00318	CcSEcCtD
Brimonidine—Skin disorder—Etoposide—germ cell cancer	0.000802	0.00317	CcSEcCtD
Brimonidine—ADRA2C—head—germ cell cancer	0.0008	0.0169	CbGeAlD
Brimonidine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000778	0.00308	CcSEcCtD
Brimonidine—Drowsiness—Methotrexate—germ cell cancer	0.000775	0.00307	CcSEcCtD
Brimonidine—ADRA2C—testis—germ cell cancer	0.000773	0.0163	CbGeAlD
Brimonidine—Depression—Methotrexate—germ cell cancer	0.000773	0.00306	CcSEcCtD
Brimonidine—Hypotension—Etoposide—germ cell cancer	0.000771	0.00305	CcSEcCtD
Brimonidine—Rash—Bleomycin—germ cell cancer	0.000771	0.00305	CcSEcCtD
Brimonidine—Pain—Cisplatin—germ cell cancer	0.00077	0.00305	CcSEcCtD
Brimonidine—Dermatitis—Bleomycin—germ cell cancer	0.00077	0.00305	CcSEcCtD
Brimonidine—Hypersensitivity—Ifosfamide—germ cell cancer	0.00077	0.00305	CcSEcCtD
Brimonidine—Conjunctivitis—Methotrexate—germ cell cancer	0.000754	0.00298	CcSEcCtD
Brimonidine—Asthenia—Ifosfamide—germ cell cancer	0.00075	0.00297	CcSEcCtD
Brimonidine—ADRA2A—adrenal gland—germ cell cancer	0.000746	0.0158	CbGeAlD
Brimonidine—Paraesthesia—Etoposide—germ cell cancer	0.000741	0.00294	CcSEcCtD
Brimonidine—Pruritus—Ifosfamide—germ cell cancer	0.000739	0.00293	CcSEcCtD
Brimonidine—ADRA2A—midbrain—germ cell cancer	0.000737	0.0156	CbGeAlD
Brimonidine—Dyspnoea—Etoposide—germ cell cancer	0.000736	0.00291	CcSEcCtD
Brimonidine—Somnolence—Etoposide—germ cell cancer	0.000734	0.00291	CcSEcCtD
Brimonidine—Nausea—Bleomycin—germ cell cancer	0.000726	0.00288	CcSEcCtD
Brimonidine—Rash—Dactinomycin—germ cell cancer	0.000719	0.00285	CcSEcCtD
Brimonidine—ADRA2A—spinal cord—germ cell cancer	0.000719	0.0152	CbGeAlD
Brimonidine—ADRA2C—cerebellum—germ cell cancer	0.000714	0.0151	CbGeAlD
Brimonidine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000713	0.00282	CcSEcCtD
Brimonidine—Fatigue—Etoposide—germ cell cancer	0.000712	0.00282	CcSEcCtD
Brimonidine—Pain—Etoposide—germ cell cancer	0.000706	0.0028	CcSEcCtD
Brimonidine—ADRA2A—female gonad—germ cell cancer	0.000696	0.0147	CbGeAlD
Brimonidine—Dizziness—Ifosfamide—germ cell cancer	0.000691	0.00274	CcSEcCtD
Brimonidine—Pharyngitis—Methotrexate—germ cell cancer	0.000691	0.00274	CcSEcCtD
Brimonidine—Nausea—Dactinomycin—germ cell cancer	0.000677	0.00268	CcSEcCtD
Brimonidine—Visual impairment—Methotrexate—germ cell cancer	0.000671	0.00266	CcSEcCtD
Brimonidine—Hypersensitivity—Cisplatin—germ cell cancer	0.000664	0.00263	CcSEcCtD
Brimonidine—Rash—Ifosfamide—germ cell cancer	0.000659	0.00261	CcSEcCtD
Brimonidine—Dermatitis—Ifosfamide—germ cell cancer	0.000658	0.00261	CcSEcCtD
Brimonidine—Eye disorder—Methotrexate—germ cell cancer	0.00065	0.00258	CcSEcCtD
Brimonidine—ADRA2A—endocrine gland—germ cell cancer	0.000647	0.0137	CbGeAlD
Brimonidine—Asthenia—Cisplatin—germ cell cancer	0.000646	0.00256	CcSEcCtD
Brimonidine—Cardiac disorder—Methotrexate—germ cell cancer	0.000646	0.00256	CcSEcCtD
Brimonidine—ADRA2A—head—germ cell cancer	0.000639	0.0135	CbGeAlD
Brimonidine—Angiopathy—Methotrexate—germ cell cancer	0.000631	0.0025	CcSEcCtD
Brimonidine—Immune system disorder—Methotrexate—germ cell cancer	0.000629	0.00249	CcSEcCtD
Brimonidine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000627	0.00248	CcSEcCtD
Brimonidine—Nausea—Ifosfamide—germ cell cancer	0.000621	0.00246	CcSEcCtD
Brimonidine—ADRA2A—testis—germ cell cancer	0.000617	0.013	CbGeAlD
Brimonidine—Mental disorder—Methotrexate—germ cell cancer	0.00061	0.00241	CcSEcCtD
Brimonidine—Hypersensitivity—Etoposide—germ cell cancer	0.000608	0.00241	CcSEcCtD
Brimonidine—Erythema—Methotrexate—germ cell cancer	0.000606	0.0024	CcSEcCtD
Brimonidine—Dysgeusia—Methotrexate—germ cell cancer	0.000593	0.00235	CcSEcCtD
Brimonidine—Asthenia—Etoposide—germ cell cancer	0.000592	0.00235	CcSEcCtD
Brimonidine—Pruritus—Etoposide—germ cell cancer	0.000584	0.00231	CcSEcCtD
Brimonidine—ADRA2C—brain—germ cell cancer	0.00058	0.0123	CbGeAlD
Brimonidine—Vision blurred—Methotrexate—germ cell cancer	0.000571	0.00226	CcSEcCtD
Brimonidine—ADRA2A—cerebellum—germ cell cancer	0.00057	0.012	CbGeAlD
Brimonidine—Rash—Cisplatin—germ cell cancer	0.000568	0.00225	CcSEcCtD
Brimonidine—Dermatitis—Cisplatin—germ cell cancer	0.000568	0.00225	CcSEcCtD
Brimonidine—ADRA2C—lymph node—germ cell cancer	0.00056	0.0118	CbGeAlD
Brimonidine—Dizziness—Etoposide—germ cell cancer	0.000546	0.00216	CcSEcCtD
Brimonidine—Nausea—Cisplatin—germ cell cancer	0.000535	0.00212	CcSEcCtD
Brimonidine—Cough—Methotrexate—germ cell cancer	0.000529	0.00209	CcSEcCtD
Brimonidine—Rash—Etoposide—germ cell cancer	0.00052	0.00206	CcSEcCtD
Brimonidine—Dermatitis—Etoposide—germ cell cancer	0.00052	0.00206	CcSEcCtD
Brimonidine—Headache—Etoposide—germ cell cancer	0.000517	0.00205	CcSEcCtD
Brimonidine—Myalgia—Methotrexate—germ cell cancer	0.000516	0.00204	CcSEcCtD
Brimonidine—Arthralgia—Methotrexate—germ cell cancer	0.000516	0.00204	CcSEcCtD
Brimonidine—Chest pain—Methotrexate—germ cell cancer	0.000516	0.00204	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000512	0.00203	CcSEcCtD
Brimonidine—Discomfort—Methotrexate—germ cell cancer	0.00051	0.00202	CcSEcCtD
Brimonidine—Infection—Methotrexate—germ cell cancer	0.000491	0.00195	CcSEcCtD
Brimonidine—Nausea—Etoposide—germ cell cancer	0.00049	0.00194	CcSEcCtD
Brimonidine—Nervous system disorder—Methotrexate—germ cell cancer	0.000485	0.00192	CcSEcCtD
Brimonidine—Skin disorder—Methotrexate—germ cell cancer	0.00048	0.0019	CcSEcCtD
Brimonidine—ADRA2A—brain—germ cell cancer	0.000463	0.00978	CbGeAlD
Brimonidine—Hypotension—Methotrexate—germ cell cancer	0.000462	0.00183	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00045	0.00178	CcSEcCtD
Brimonidine—Insomnia—Methotrexate—germ cell cancer	0.000447	0.00177	CcSEcCtD
Brimonidine—ADRA2A—lymph node—germ cell cancer	0.000447	0.00945	CbGeAlD
Brimonidine—Paraesthesia—Methotrexate—germ cell cancer	0.000444	0.00176	CcSEcCtD
Brimonidine—Dyspnoea—Methotrexate—germ cell cancer	0.000441	0.00175	CcSEcCtD
Brimonidine—Somnolence—Methotrexate—germ cell cancer	0.00044	0.00174	CcSEcCtD
Brimonidine—Dyspepsia—Methotrexate—germ cell cancer	0.000435	0.00172	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000427	0.00169	CcSEcCtD
Brimonidine—Fatigue—Methotrexate—germ cell cancer	0.000426	0.00169	CcSEcCtD
Brimonidine—Pain—Methotrexate—germ cell cancer	0.000423	0.00167	CcSEcCtD
Brimonidine—Hypersensitivity—Methotrexate—germ cell cancer	0.000364	0.00144	CcSEcCtD
Brimonidine—Asthenia—Methotrexate—germ cell cancer	0.000355	0.0014	CcSEcCtD
Brimonidine—Pruritus—Methotrexate—germ cell cancer	0.00035	0.00139	CcSEcCtD
Brimonidine—Dizziness—Methotrexate—germ cell cancer	0.000327	0.00129	CcSEcCtD
Brimonidine—Rash—Methotrexate—germ cell cancer	0.000312	0.00123	CcSEcCtD
Brimonidine—Dermatitis—Methotrexate—germ cell cancer	0.000311	0.00123	CcSEcCtD
Brimonidine—Headache—Methotrexate—germ cell cancer	0.00031	0.00123	CcSEcCtD
Brimonidine—Nausea—Methotrexate—germ cell cancer	0.000294	0.00116	CcSEcCtD
